Manufacturer record
GP Glister Pharmaceutical: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by GP Glister Pharmaceutical was declared Not of Standard Quality in April 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: PZ-2414, Povigin (Povidone Iodine Ointment USP 5%w/w) (exp Aug 2026). DTL Chennai (state lab) found it not of standard quality: Sample does not conform to USP specification for Povidone- Iodine Ointment with respect to the content of Available Iodine in Povidone. Listed in the April 2025 alert.
Records by type
1 record linked to GP Glister Pharmaceutical in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Povigin (Povidone Iodine Ointment USP 5%w/w) | Batch PZ-2414Mfg Sep 2024 · Exp Aug 2026 | Sample does not conform to USP specification for Povidone- Iodine Ointment with respect to the content of Available Iodine in Povidone- IodineOther | DTL ChennaiState lab | Apr 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.